Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and single-cell analysis of prognostic genes related to mitochondrial and neutrophil extracellular traps in bladder cancer. | Sci Rep | 2025 | 40615671 | PubTator, text mining | PubMed |
| The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis. | Front Immunol | 2025 | 40607391 | PubTator, text mining | PubMed |
| Synthetic biology-driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer. | Sci Transl Med | 2025 | 40531967 | PubTator, text mining | PubMed |
| Targeting B and T lymphocyte attenuator in cancer immunotherapy. | Int J Biol Macromol | 2025 | 40480574 | PubTator, text mining | PubMed |
| Genetic insights into the causal associations between immune cells and ovarian aging in the European population. | Climacteric | 2025 | 40464911 | PubTator, text mining | PubMed |
| Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer. | Cancers (Basel) | 2025 | 40427227 | PubTator, text mining | PubMed |
| Distinct genetic alterations in CD10-negative MUM1-positive follicular lymphoma. | Pathology | 2025 | 40393874 | PubTator, text mining | PubMed |
| Medical school admission processes to target rural applicants: an international scoping review and mapping of Australian practices. | BMC Med Educ | 2025 | 40329283 | PubTator, text mining | PubMed |
| Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients. | Int J Mol Sci | 2025 | 40243455 | PubTator, text mining | PubMed |
| Decoding the causal association between immune cells and three chronic respiratory diseases: Insights from a bi-directional Mendelian randomization study. | BMC Pulm Med | 2025 | 40234829 | PubTator, text mining | PubMed |
| A novel approach utilizing spirocyclic thiopyrimidinone compounds against herpes simplex virus with underlying antiviral mechanisms of action. | Virol J | 2025 | 40217544 | PubTator, text mining | PubMed |
| Exploring new drug treatment targets for immune related bone diseases using a multi omics joint analysis strategy. | Sci Rep | 2025 | 40148470 | PubTator, text mining | PubMed |
| Multi-omic biomarkers associated with multiple sclerosis: from Mendelian randomization to drug prediction. | Sci Rep | 2025 | 40108295 | PubTator, text mining | PubMed |
| Quantitative detection of the HVEM-BTLA checkpoint receptor cis-complex in human lymphocytes. | J Immunol | 2025 | 40073094 | PubTator, text mining | PubMed |
| Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA. | Hemasphere | 2025 | 40060117 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Single-Cell and Bulk Transcriptomics Identified Regulatory T-Cell Features as Predictors of Prognosis in Diffuse Large B-Cell Lymphoma. | Hematol Oncol | 2025 | 40041930 | PubTator, text mining | PubMed |
| The Function of B and T Lymphocyte Attenuator and Its Role in Transplantation. | APMIS | 2025 | 40040475 | PubTator, text mining | PubMed |
| Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer. | Front Immunol | 2025 | 40034693 | PubTator, text mining | PubMed |
| Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy. | Viruses | 2025 | 40007004 | PubTator, text mining | PubMed |
| Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells. | Int J Mol Sci | 2025 | 40004038 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=8